GENE ONLINE|News &
Opinion
Blog

2021-01-24| ChinaCOVID-19

Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center

by Tyler Chen
Share To

Outside Shijiazhuang, Hebei province, over 4,000 construction workers are building a giant quarantine center of 4,156 units that can house COVID-19 patients within days of diagnosis.

 

New Wave of COVID-19 Cases

According to WHO’s data, China has 99,414 confirmed cases of COVID-19 with 4,808 deaths as of January 21st. As the Lunar New Year approaches, China expects a new wave of COVID-19 cases where city residents are traveling across the country to meet their families. To alleviate the burden on the healthcare system, China has started constructing a new quarantine location on January 13th on the outskirts of Northern China.

 

Quarantine Unit

Each unit in the quarantine center is equipped with basic facilities, including internet, bathroom, bedroom, air conditioning, etc. District 1 is currently moving to the last phase. Most of the infrastructures are done with air conditioning and water heaters waiting to be installed. Within days, China has successfully delivered 606 units and is estimated to reach 1,779 in total by the end of January.

 

Individual Testing of COVID-19

Furthermore, China has scheduled to perform a COVID-19 testing plan in the quarantine center for each individual. Every personnel and quarantine related parties will undergo a nucleic acid amplification testing (NAAT) for COVID-19 from January 20 to 22nd, and there will be 28 testing companies for professional and efficient screening.

Related Article: COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic

References
  1. http://www.gov.cn/xinwen/2021-01/19/content_5581124.htm#1
  2. http://www.sjz.gov.cn/col/1609405465981/2021/01/21/1611190892875.html
  3. http://www.sjz.gov.cn/col/1596014213243/2021/01/20/1611105496040.html
  4. https://www.163.com/dy/article/G0SLI3JB0514R9KE.html

 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma
2024-08-21
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
LATEST
2024 Nobel Prize in Medicine: Uncovering the Secrets of microRNA in Gene Regulation
2024-10-08
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
2024-10-07
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top